Anti-retrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 646-648

  Antonini, Mario ^a,c   Ettorre, Giuseppe Maria ^a   Vennarecci, Giovanni ^a   D'Offizi, Gianpiero ^b   Narciso, Pasquale ^b   Del Nonno, Franca ^a   Perracchio, Letizia ^a   Visco, Giuseppe ^a   Santoro, Eugenio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c Istituti Fisioterapici Ospitalieri Rome   (Italy)

Author keywords

Anti retrovirals; GSH; Rhabdomyolysis; Riboflavin; Tacrolimus

Indexed keywords

ANTIRETROVIRUS AGENT; AZATHIOPRINE; EFAVIRENZ; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; RIBOFLAVIN; STEROID; TACROLIMUS; ZIDOVUDINE;

ADULT; ARTICLE; ASCITES; BODY WEIGHT; CASE REPORT; CELL COUNT; GRAFT REJECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MYOGLOBINURIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RHABDOMYOLYSIS; T LYMPHOCYTE;

ANTI-RETROVIRAL AGENTS; DRUG INTERACTIONS; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 2342588112     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Roland M, Stock PG: Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75:425-429.
2. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ: Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9:238-247.
3. Sugawara Y, Ohkubo T, Makuuchi M, Kimura S, Morisawa Y, Tachikawa N, Oka S: Living-donor liver transplantation in an HIV-positive patient with hemophilia. Transplantation 2002; 74:1865-1866.
4. Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE: Transplantation in HIV+ patients. Transplantation 1990; 49:354-358.
5. Prachalias AA, Pozniak A, Taylor C, Srinivasan, Muiesan P, Wendon J, Cramp M, Williams R, O'Grady J, Rela M, Heaton ND: Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72:1684-1688.
6. Jain AK, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Ragni M, Fung JJ: The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 2002; 8:841-843.
7. Liddle C, Goodwill B: Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR. Semin Liver Dis 2002; 22:115-119.
8. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD: Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 2002; 35:182-189.
9. Fouty B, Frerman F, Reves R: Riboflavin to treat nucleoside analogue-induced lactic acidosis. The Lancet 1998; 352:291-292.
10. Kaplowitz N: Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002; 22:137-143.
11. Brown SJ, Desmond PV: Hepatotoxicity of antimicrobial agents. Semin Liver Dis 2002; 22:157-166.